(19)
(11) EP 0 900 217 A1

(12)

(43) Date of publication:
10.03.1999 Bulletin 1999/10

(21) Application number: 97918771.0

(22) Date of filing: 23.04.1997
(51) International Patent Classification (IPC): 
A61K 31/ 00( . )
A61K 31/ 433( . )
A61K 31/ 4427( . )
A61P 1/ 00( . )
A61P 9/ 10( . )
A61P 43/ 00( . )
C07D 417/ 14( . )
A61K 31/ 41( . )
A61K 31/ 44( . )
A61K 31/ 444( . )
A61P 9/ 00( . )
A61P 25/ 04( . )
C07D 417/ 12( . )
(86) International application number:
PCT/US1997/006679
(87) International publication number:
WO 1997/040042 (30.10.1997 Gazette 1997/46)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

(30) Priority: 23.04.1996 US 19960016009P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • MERRITT, Leander
    Indianapolis, IN 46208 (US)
  • JEPPSON, Lone
    DK-Coppenhagen (DK)
  • WARD, John, S.
    Indianapolis, IN 46227 (US)

(74) Representative: Hudson, Christopher Mark, et al 
Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor
Windlesham Surrey GU20 6PH
Windlesham Surrey GU20 6PH (GB)

   


(54) HETEROCYCLIC COMPOUNDS